23andMe sold out of bankruptcy to Regeneron
Drugmaker’s takeover could raise privacy concerns among genetics start-up’s 15mn users
Drugmaker Regeneron Pharmaceuticals’ capture of genetic testing firm in bankruptcy auction raises privacy concerns
The drugmaker Regeneron Pharmaceuticals has agreed to buy the genetic testing firm 23…